This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., Byk Gulden Lomberg Chemische Fabrik Gmbh. Active years: 1999-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2019
Title: The Innovative Journey of Steven Shak
Introduction
Steven Shak is a prominent inventor based in Burlingame, California, with a significant impact in the field of medical innovations. With a total of eight patents to his name, his work predominantly focuses on advancements in cancer treatment methodologies using antibody therapies.
Latest Patents
Among his latest patents are groundbreaking inventions concerning dosages for the treatment of human cancer patients with anti-Epidermal Growth Factor Receptor (EGFR) antibodies. These inventions are pivotal as they enhance the therapeutic effectiveness for patients suffering from various forms of cancer, showcasing his dedication to improving healthcare outcomes.
Career Highlights
Steven Shak has made notable contributions while working in esteemed companies in the biotechnology sector, including Genentech, Inc. and Byk Gulden Lomberg Chemische Fabrik GmbH. His expertise in the development of health-related innovations has firmly established him as a key figure in the industry.
Collaborations
Throughout his career, Shak has collaborated with talented professionals, including coworkers Sharon A. Baughman and Virginia E. Paton. These partnerships have facilitated an exchange of ideas and empowered collective efforts towards pioneering treatments and solutions in cancer therapy.
Conclusion
Steven Shak's journey as an inventor reflects his commitment to advancing medical technologies and improving patient care. His innovative patents and collaborative work illustrate the potential for transformative healthcare solutions in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

